|1.||Nishida, Yoshihiro: 6 articles (12/2015 - 03/2006)|
|2.||Ishiguro, Naoki: 6 articles (12/2015 - 03/2006)|
|3.||Seewald, Wolfgang: 5 articles (01/2015 - 11/2003)|
|4.||Budsberg, Steven C: 5 articles (09/2013 - 11/2002)|
|5.||Flecknell, Paul A: 5 articles (01/2012 - 01/2003)|
|6.||Xu, Zongzhen: 4 articles (12/2015 - 12/2006)|
|7.||Urakawa, Hiroshi: 4 articles (12/2015 - 01/2012)|
|8.||Li, Jie: 4 articles (12/2015 - 12/2006)|
|9.||Coetzee, J F: 4 articles (05/2015 - 02/2013)|
|10.||King, Jonathan N: 4 articles (01/2015 - 02/2011)|
03/01/2001 - "Meloxicam 7.5 mg and 15 mg significantly improved overall pain between baseline and day 7 (p < 0.05) compared with placebo. "
01/01/1998 - "Both meloxicam 7.5 mg and 15 mg were significantly more effective than placebo with respect to pain on movement (p < 0.01 and p < 0.03, respectively). "
07/01/2015 - "Transmucosal delivery of meloxicam was found to be effective and safe in postsurgical pain control of periodontal flap surgery. "
06/01/2010 - "Changes in behavior suggest that meloxicam was effective for reducing post-surgical pain and distress associated with calf dehorning."
10/01/2014 - "To assess the efficacy of oral transmucosal meloxicam for pain relief in lambs at marking. "
10/01/2001 - "Results from this study suggest that oral meloxicam 7.5 mg for 28 days is a safe and effective treatment regimen with high GI tolerability profile for the treatment of osteoarthritis in Thai patients."
09/01/2006 - "Meloxicam has shown good clinical efficacy for the treatment of osteoarthritis and other painful conditions in large felids. "
10/01/2001 - "A prospective, open trial to evaluate the safety and efficacy of oral meloxicam 7.5 mg once daily over a period of 28 days in Thai patients with osteoarthritis was conducted in 3 major hospitals in Bangkok, Thailand. "
10/23/2000 - "In previous studies, meloxicam has been found to be safe and effective in the treatment of osteoarthritis (OA) at doses of 7.5 to 15 mg daily. "
05/01/1996 - "This 12-week, open-label, multicenter study assessed the safety, tolerability, and efficacy of the tablet formulation of meloxicam 15 mg, a new, nonsteroidal antiinflammatory drug (NSAID), in patients with confirmed osteoarthritis (OA) of the hip or knee. "
03/01/2013 - "Meloxicam was also significantly superior to dexketoprofen in reducing inflammation (p = .006). "
08/01/2011 - "Five end points of clinical interest (body temperature, creeping time under a tunnel, paw withdrawal latency to a standardized thermal stimulus, lameness score, and vertical force developed during walking on a force plate) were measured regularly over the next 24 h and beyond to characterize the time development of the inflammation either in control conditions (placebo period) or after the administration of meloxicam (test period) according to a crossover design. "
07/01/2011 - "Meloxicam seems to exert its inhibitory effect on the expression of specific genes of inflammation, as well as the combination therapy. "
09/01/2009 - "Meloxicam is a commonly used nonsteroidal anti-inflammatory drug in equine practice, but little is known about its in vivo effects on joint inflammation and cartilage turnover. "
06/01/2008 - "At most time points, the mean concentration of meloxicam in plasma exceeded the concentrations in exudate indicating a limited accumulation of the drug at the site of the inflammation. "
11/01/2004 - "Preoperative administration of meloxicam is a safe and effective method of controlling postoperative pain for up to 24 hours in dogs undergoing orthopedic surgery. "
01/01/2009 - "To assess the efficacy of single dose oral meloxicam in acute postoperative pain, and any associated adverse events. "
01/01/2009 - "No studies were identified by the searches that examined oral meloxicam in patients with established postoperative pain. "
01/01/2009 - "Randomised, double-blind, placebo-controlled clinical trials of oral meloxicam for relief of acute postoperative pain in adults. "
01/01/2011 - "No differences were noted in early postoperative pain between dogs treated with IA meloxicam, SC meloxicam, or placebo. "
04/01/1996 - "A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis."
01/01/2003 - "To perform a nonlinear mixed effect modelling (NONMEM) population pharmacokinetic analysis of meloxicam plasma concentrations in rheumatoid arthritis (RA) patients participating in three clinical trials, and to evaluate the effects of age, weight, gender and concomitant medications on meloxicam pharmacokinetics. "
04/01/1996 - "A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis."
09/01/2006 - "Meloxicam is a nonsteroidal antiinflammatory drug, used in the treatment of rheumatoid arthritis and oestoarthritis. "
04/26/2006 - "A pulsatile release of meloxicam was demonstrated by a simple drug delivery system which could be useful in chronopharmacotherapy of rheumatoid arthritis."
|1.||Diclofenac (SR 38)
|3.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|4.||Cyclooxygenase 2 (Cyclooxygenase-2)
|8.||flunixin meglumine (Banamine)
|9.||Uric Acid (Urate)
|1.||Drug Therapy (Chemotherapy)